Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Fast and economic immobilization methods described for non-commercial Pseudomonas lipases.

Cesarini S, Infanzón B, Pastor FI, Diaz P.

BMC Biotechnol. 2014 Apr 22;14:27. doi: 10.1186/1472-6750-14-27.

PMID:
24755191
[PubMed - in process]
Free PMC Article
2.

Combining phospholipases and a liquid lipase for one-step biodiesel production using crude oils.

Cesarini S, Haller RF, Diaz P, Nielsen PM.

Biotechnol Biofuels. 2014 Feb 26;7(1):29. doi: 10.1186/1754-6834-7-29.

PMID:
24571739
[PubMed]
Free PMC Article
3.

Lipase improvement: goals and strategies.

Bassegoda A, Cesarini S, Diaz P.

Comput Struct Biotechnol J. 2012 Oct 15;2:e201209005. doi: 10.5936/csbj.201209005. eCollection 2012. Review. No abstract available.

PMID:
24688646
[PubMed]
Free PMC Article
4.

Genetic relationships among Italian and Mexican maize-rhizosphere Burkholderia cepacia complex (BCC) populations belonging to Burkholderia cenocepacia IIIB and BCC6 group.

Bevivino A, Costa B, Cantale C, Cesarini S, Chiarini L, Tabacchioni S, Caballero-Mellado J, Dalmastri C.

BMC Microbiol. 2011 Oct 13;11:228. doi: 10.1186/1471-2180-11-228.

PMID:
21995705
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A virtual screening hit reveals new possibilities for developing group III metabotropic glutamate receptor agonists.

Selvam C, Oueslati N, Lemasson IA, Brabet I, Rigault D, Courtiol T, Cesarini S, Triballeau N, Bertrand HO, Goudet C, Pin JP, Acher FC.

J Med Chem. 2010 Apr 8;53(7):2797-813. doi: 10.1021/jm901523t.

PMID:
20218620
[PubMed - indexed for MEDLINE]
6.

CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists.

Cichero E, Cesarini S, Mosti L, Fossa P.

J Mol Model. 2010 Sep;16(9):1481-98. doi: 10.1007/s00894-010-0664-1. Epub 2010 Feb 20.

PMID:
20174844
[PubMed - indexed for MEDLINE]
7.

CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists.

Cichero E, Cesarini S, Mosti L, Fossa P.

J Mol Model. 2010 Apr;16(4):677-91. doi: 10.1007/s00894-009-0580-4. Epub 2009 Oct 1.

PMID:
19809837
[PubMed - indexed for MEDLINE]
8.

RecA gene sequence and Multilocus Sequence Typing for species-level resolution of Burkholderia cepacia complex isolates.

Cesarini S, Bevivino A, Tabacchioni S, Chiarini L, Dalmastri C.

Lett Appl Microbiol. 2009 Nov;49(5):580-8. doi: 10.1111/j.1472-765X.2009.02709.x. Epub 2009 Aug 7.

PMID:
19732325
[PubMed - indexed for MEDLINE]
9.

Parallel synthesis of O-phenoxyethyl and O-adamantyl N-acyl thiocarbamates endowed with antiproliferative activity.

Spallarossa A, Cesarini S, Schenone S, Ranise A.

Arch Pharm (Weinheim). 2009 Jun;342(6):344-52. doi: 10.1002/ardp.200800212.

PMID:
19517466
[PubMed - indexed for MEDLINE]
10.

6-amino-4-oxo-1,3-diphenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonyl derivatives as a new class of potent inhibitors of Interleukin-8-induced neutrophil chemotaxis.

Cesarini S, Spallarossa A, Ranise A, Bruno O, Arduino N, Bertolotto M, Dallegri F, Tognolini M, Gobbetti T, Barocelli E.

Bioorg Med Chem. 2009 May 15;17(10):3580-7. doi: 10.1016/j.bmc.2009.04.006. Epub 2009 Apr 11.

PMID:
19394230
[PubMed - indexed for MEDLINE]
11.

Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.

Cichero E, Cesarini S, Spallarossa A, Mosti L, Fossa P.

J Mol Model. 2009 Jul;15(7):871-84. doi: 10.1007/s00894-008-0441-6. Epub 2009 Jan 20.

PMID:
19153780
[PubMed - indexed for MEDLINE]
12.

Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor.

Cichero E, Cesarini S, Spallarossa A, Mosti L, Fossa P.

J Mol Model. 2009 Apr;15(4):357-67. doi: 10.1007/s00894-008-0402-0. Epub 2008 Dec 9.

PMID:
19066996
[PubMed - indexed for MEDLINE]
13.

Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Spallarossa A, Cesarini S, Ranise A, Schenone S, Bruno O, Borassi A, La Colla P, Pezzullo M, Sanna G, Collu G, Secci B, Loddo R.

Eur J Med Chem. 2009 May;44(5):2190-201. doi: 10.1016/j.ejmech.2008.10.032. Epub 2008 Nov 5.

PMID:
19058881
[PubMed - indexed for MEDLINE]
14.

Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.

Cichero E, Cesarini S, Fossa P, Spallarossa A, Mosti L.

Eur J Med Chem. 2009 May;44(5):2059-70. doi: 10.1016/j.ejmech.2008.10.014. Epub 2008 Nov 1.

PMID:
19046616
[PubMed - indexed for MEDLINE]
15.

Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors.

Spallarossa A, Cesarini S, Ranise A, Bruno O, Schenone S, La Colla P, Collu G, Sanna G, Secci B, Loddo R.

Eur J Med Chem. 2009 Apr;44(4):1650-63. doi: 10.1016/j.ejmech.2008.09.024. Epub 2008 Sep 30.

PMID:
18954921
[PubMed - indexed for MEDLINE]
16.

N-acylated and N,N'-diacylated imidazolidine-2-thione derivatives and N,N'-diacylated tetrahydropyrimidine-2(1H)-thione analogues: synthesis and antiproliferative activity.

Cesarini S, Spallarossa A, Ranise A, Schenone S, Rosano C, La Colla P, Sanna G, Busonera B, Loddo R.

Eur J Med Chem. 2009 Mar;44(3):1106-18. doi: 10.1016/j.ejmech.2008.06.010. Epub 2008 Jun 24.

PMID:
18667259
[PubMed - indexed for MEDLINE]
17.

Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Cesarini S, Spallarossa A, Ranise A, Schenone S, Bruno O, La Colla P, Casula L, Collu G, Sanna G, Loddo R.

Bioorg Med Chem. 2008 Jun 15;16(12):6353-63. doi: 10.1016/j.bmc.2008.05.010. Epub 2008 May 7.

PMID:
18502646
[PubMed - indexed for MEDLINE]
18.

Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate.

Cesarini S, Spallarossa A, Ranise A, Bruno O, La Colla P, Secci B, Collu G, Loddo R.

Bioorg Med Chem. 2008 Apr 1;16(7):4173-85. doi: 10.1016/j.bmc.2007.12.046. Epub 2007 Dec 25.

PMID:
18226533
[PubMed - indexed for MEDLINE]
19.

Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates.

Cesarini S, Spallarossa A, Ranise A, Fossa P, La Colla P, Sanna G, Collu G, Loddo R.

Bioorg Med Chem. 2008 Apr 1;16(7):4160-72. doi: 10.1016/j.bmc.2007.12.050. Epub 2007 Dec 25.

PMID:
18226532
[PubMed - indexed for MEDLINE]
20.

Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.

Spallarossa A, Cesarini S, Ranise A, Ponassi M, Unge T, Bolognesi M.

Biochem Biophys Res Commun. 2008 Jan 25;365(4):764-70. Epub 2007 Nov 21.

PMID:
18035053
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk